Recipharm has successfully received European Medicines Verification Organization (EMVO) approval to submit serialization data to the European Hub. The connection, which was facilitated by the company’s strategic partner TraceLink, is a key milestone in Recipharm’s preparations for the Falsified Medicines Directive (FMD). While clients of Recipharm’s CDMO business must establish their own connections to the EU Hub for their products, the connection allows the marketing authorisation holder...